Please login to the form below

Not currently logged in
Email:
Password:

cancer drug funding

This page shows the latest cancer drug funding news and features for those working in and with pharma, biotech and healthcare.

Cancer charities criticise NICE's 'last-century methodology'

Cancer charities criticise NICE's 'last-century methodology'

Group of 15 claims many new prostate cancer drugs will now ‘struggle to gain approval’.  . ... cancer drugs funding,” said the charity's chief executive Mark Flanagan.

Latest news

  • England's Cancer Drugs Fund: Fixing a broken system England's Cancer Drugs Fund: Fixing a broken system

    Meanwhile, shortly after the de-listing announcement, the Anglo-Swedish firm AstraZeneca said it would not even bother putting its newly approved ovarian cancer drug Lynparza (olaparib) up for funding via ... sustainable solution to cancer drug access

  • Decision to withdraw Jevtana in England ‘flawed’ Decision to withdraw Jevtana in England ‘flawed’

    Urologists and oncologists attack NHS England’s de-listing of Sanofi’s drug. A UK charity has denounced NHS England's decision to withdraw a new prostate cancer drug from its ... It is currently the only treatment for hormone resistant advanced

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Engaging the digital healthcare professional Engaging the digital healthcare professional

    When NICE, the UK policymaker for health spending, rejected Pfizer’s breast cancer drug palbociclib for routine funding on the NHS in February, it tweeted the news and invited comments on ... It was also shared by a student midwife who tweeted to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics